Plus: European lawmakers are considering stopping a vote on a trade deal with the U.S. in light of last week’s Supreme Court ruling on tariffs. And Novo Nordisk shares fell sharply after its experimental obesity drug failed to beat out Eli Lilly’s Zepbound. Alex Ossola hosts.

Sign up for WSJ’s free What’s News newsletter.

An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Learn more about your ad choices. Visit megaphone.fm/adchoices